According to the American Association of University Women, women are losing $500 billion each year because of the gender pay gap. Pexels

National Equal Pay Day, which symbolizes how far into the year women must work to earn what men earned in the previous year, falls on April 2 this year and marks a 56-year effort across the nation to have employers address the gender pay gap and provide equal pay for equal work.

That effort is now, closer than ever, to reality as the U.S. House of Representatives, in a heartening move this week, passed the bipartisan Paycheck Fairness Act, authored by Congresswoman Rosa DeLauro and co-sponsored by newly elected Texas Congressman Colin Allred.

The act, among other things, would require employers to prove that pay disparities exist for legitimate job-related reasons, prohibit employers from relying on salary history in determining future pay, provide assistance to all businesses to help them with their equal pay practices and recognize excellence in pay practices by businesses. It would also get rid of rules imposed by employers that prohibit workers from talking about their salary, so women are permitted to ask how much their coworkers are making and find out if they are underpaid.

This legislation is a leap forward in closing the persistent and woeful gender pay.

Statistics show that although more women, nationally, are receiving undergraduate and graduate degrees compared to men, and are equally qualified for the work as their male counterparts, they continue to receive about 82 cents for every dollar earned by men, and women of color earn even less (e.g. Black women earn 63 cents for every dollar and Hispanic women earn just 54 cents for every dollar). At this rate, without any affirmative or proactive changes, it will take another 51 years for women to catch up to men's wages.

In Texas, the outlook around women's pay and the gender gap is grim.

According to the Texas Women's Foundation, in Dallas County, women made almost 93 percent of what men earned, compared to just about 70 percent in Collin County and a little more than 76 percent in Denton County.

According to the American Association of University Women, women are losing $500 billion each year because of the gender pay gap. U.S. corporations suffering those kind of financial losses would send shockwaves through our economic system.

If women made the same pay as men, they would not only be able to better care for their families, but put aside more money in their retirement or pension funds, pay off college loans and mortgages, and enjoy better healthcare and a healthier lifestyle. Research by the Texas Women's Foundation has shown that if working women in Texas were paid the same wages comparable to men, the poverty rate would be reduced by 51 percent.

Companies should not just support the Paycheck Fairness Act, but also become assertive about equal pay and gender diversity, and treat them as an integral part of their business strategy. In order for businesses to truly benefit from the myriad of backgrounds and experiences in our global economy, we must ensure a level-playing field for women and other underrepresented employees. Then and only then will our nation's workplaces and businesses truly thrive. Mr. President and senators — let us pass the Paycheck Fairness Act now.

------

Mandy Price is the CEO and co-founder of Dallas-based Kanarys Inc., a web platform that incorporates data and AI to foster diversity, equity, and inclusion in the workplace.

Just making sure your workplace is diverse isn't enough to solve the problem. Inclusion should be just as important of a goal, says this expert. Getty Images

Data-driven inclusion platform founder says ensuring your workplace is diverse just isn't enough

Guest column

Business leaders have long recognized that a diverse and inclusive workforce results in greater employee engagement, innovation, financial returns and market share. Although the "business case" for diversity has long been proven over the years, and "diversity" has become a buzzword adopted by corporate America, few companies — big or small, new or old — have been able to cultivate real inclusion, acceptance and collaboration in the workplace.

According to a 2018 Atlassian study, State of Diversity and Inclusion in U.S. Tech, less than 30 percent of underrepresented employees feel a sense of belonging in their workplace. By and large, most diversity and inclusion initiatives focus primarily on recruitment and increasing the representation of various demographics in the workforce, with little attention given to inclusion — although research has shown that increases to diversity alone do not improve inclusion.

One reason companies have focused on diversity, as opposed to inclusion, is because it is easy to measure diversity — it is simply a matter of headcount. Traditionally, trying to quantify feelings of inclusion was difficult for organizations to measure. However, it is important to incorporate quantifiable and data-driven strategies to measure inclusion, in order to drive the necessary cultural and structural changes needed in the workplace.

What many companies struggle with, it turns out, is not solving problems, but figuring out what the problems actually are—especially when it comes to creating inclusive workplaces. At Kanarys, we have constructed a unique and robust framework for measuring inclusion, to help companies promote a sense of belonging among their employees in the workplace. Our data-driven approach and methodology relies on artificial intelligence and responsive, anonymous, quantitative surveys, to provide actionable insights in order to promote an environment where all employees feel included and empowered.

Understanding employees' daily lived experiences in the workplace is key and fundamental to understanding an organization's' inclusiveness. However, fear of retaliation and retribution prevents most employees from holding back true and authentic feedback. Benchmarking key aspects of an organization's culture—and understanding the employee experience—is important to understand in order to promote lasting inclusion.

Diversity without inclusion inevitably results in missed opportunities with diverse talent because they no longer feel empowered to contribute and lead. However, if you have both diversity and inclusion, retention and engagement for all employees increases–resulting in a potent mix of innovation, collaboration and success.

Instead of asking "how can we acquire more diverse employees?" we should be asking, "what is it about our systems and culture that prevents us from retaining diverse talent?" Employers must therefore recognize that hiring a few "diverse" employees alone is not enough, and that inclusive cultures don't just happen. They are intentional.

I invite businesses to re-focus their efforts on true diversity, equity, and inclusion and help create workplaces where their employees have a true sense of belonging.

------

Mandy Price is the CEO and co-founder of Dallas-based Kanarys Inc., a web platform that incorporates data and AI to foster diversity, equity, and inclusion in the workplace.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.